AstraZeneca diabetes drug gets FDA approval

AstraZeneca diabetes drug gets FDA approval

This post was originally published on this site

AstraZeneca said that the US Food and Drug Administration has approved a new formulation of its type-2 diabetes treatment Bydureon. The FDA has approved Astra’s injectable suspension, a new formulation in an improved once-weekly, single-dose autoinjector device for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines in addition to diet and exercise, to improve glycaemic control.